{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:42:48Z","timestamp":1784871768080,"version":"3.55.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.beem.2023.101821","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T04:33:46Z","timestamp":1694752426000},"page":"101821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dyslipidaemia and growth hormone deficiency \u2013 A comprehensive review"],"prefix":"10.1016","volume":"37","author":[{"given":"Matthias","family":"Hepprich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahim","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuel","family":"Christ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/joim.13382","article-title":"Growth hormone deficiency in adults with hypopituitarism-What are the risks and can they be eliminated by therapy?","volume":"290","author":"Johannsson","year":"2021","journal-title":"J Intern Med"},{"issue":"10058","key":"10.1016\/j.beem.2023.101821_bib2","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/S0140-6736(16)30053-8","article-title":"Hypopituitarism","volume":"388","author":"Higham","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib3","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2023.101821_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41574-021-00539-5","article-title":"Advances in differential diagnosis and management of growth hormone deficiency in children","volume":"17","author":"Hage","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib5","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1530\/eje.1.01829","article-title":"Consensus statement on the management of the GH-treated adolescent in the transition to adult care","volume":"152","author":"Clayton","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2023.101821_bib6","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2147\/TCRM.S136576","article-title":"Childhood-onset growth hormone deficiency and the transition to adulthood: current perspective","volume":"14","author":"Ahmid","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"8710","key":"10.1016\/j.beem.2023.101821_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Ros\u00e9n","year":"1990","journal-title":"Lancet"},{"issue":"9254","key":"10.1016\/j.beem.2023.101821_bib8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib9","doi-asserted-by":"crossref","first-page":"D1","DOI":"10.1530\/EJE-21-0534","article-title":"Should patients with adult GH deficiency receive GH replacement?","volume":"186","author":"J\u00f8rgensen","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"5 Suppl","key":"10.1016\/j.beem.2023.101821_bib10","first-page":"41","article-title":"Growth hormone and the metabolic syndrome","volume":"22","author":"Johannsson","year":"1999","journal-title":"J Endocrinol Invest"},{"issue":"11","key":"10.1016\/j.beem.2023.101821_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012924","article-title":"Cholesterol and atherosclerotic cardiovascular disease: a lifelong problem","volume":"8","author":"Gidding","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ando.2023.02.002","article-title":"Why do patients with hypopituitarism still present an increased mortality?","volume":"84","author":"Ebrahimi","year":"2023","journal-title":"Ann Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2265.1994.tb02555.x","article-title":"The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients","volume":"41","author":"Russell-Jones","year":"1994","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11154-020-09599-w","article-title":"Growth hormone deficiency and replacement therapy in adults: Impact on survival","volume":"22","author":"van Bunderen","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib15","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Ros\u00e9n","year":"1993","journal-title":"Acta Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0026-0495(94)90245-3","article-title":"Serum lipid levels in growth hormone-deficient men","volume":"43","author":"de Boer","year":"1994","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib17","first-page":"82","article-title":"Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group","volume":"82","author":"Attanasio","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib18","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1210\/jcem.87.5.8474","article-title":"Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia","volume":"87","author":"Barreto-Filho","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/eje.1.02179","article-title":"Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis","volume":"155","author":"Abs","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2265.1995.tb02601.x","article-title":"Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults","volume":"42","author":"Beshyah","year":"1995","journal-title":"Clin Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib21","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0026-0495(00)80028-1","article-title":"Effects of growth hormone treatment on very-low density lipoprotein apolipoprotein B100 turnover in adult hypopituitarism","volume":"49","author":"Chrisoulidou","year":"2000","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib22","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib23","doi-asserted-by":"crossref","first-page":"e2121","DOI":"10.1210\/clinem\/dgz149","article-title":"Long-acting growth hormone preparations - current status and future considerations","volume":"105","author":"Miller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrendo.2013.77","article-title":"Diagnosis and treatment of growth hormone deficiency in adults","volume":"9","author":"Kargi","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2265.2007.02935.x","article-title":"Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy","volume":"67","author":"Monson","year":"2007","journal-title":"Clin Endocrinol"},{"issue":"Suppl A","key":"10.1016\/j.beem.2023.101821_bib26","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S1096-6374(00)90025-X","article-title":"Growth hormone (GH) replacement therapy: cancer in adults treated with GH","volume":"10","author":"Monson","year":"2000","journal-title":"Growth Horm IGF Res"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1530\/EJE-07-0364","article-title":"Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset GH deficiency","volume":"157","author":"Hoybye","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ghir.2005.06.018","article-title":"Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database","volume":"15","author":"Abs","year":"2005","journal-title":"Growth Horm IGF Res"},{"issue":"8","key":"10.1016\/j.beem.2023.101821_bib29","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1210\/jc.2005-0185","volume":"90","author":"Verhelst","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1530\/eje.1.01881","article-title":"Sheehan's syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS - Pfizer International Metabolic Database","volume":"152","author":"Kelestimur","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/eje.1.02209","article-title":"Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database","volume":"155","author":"Maiter","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"M\u00f8ller","year":"2009","journal-title":"Endocr Rev"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/diab.46.9.1453","article-title":"rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM","volume":"46","author":"Carroll","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2023.101821_bib34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1530\/eje.0.1370146","article-title":"The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults","author":"Carroll","year":"1997","journal-title":"Eur J Endocrinol 137(2"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib35","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1210\/jc.2004-2247","article-title":"Short-term effects of growth hormone (GH) treatment or deprivation on cardiovascular risk parameters and intima-media thickness at carotid arteries in patients with severe GH deficiency","volume":"90","author":"Colao","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"24","key":"10.1016\/j.beem.2023.101821_bib36","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1161\/CIRCULATIONAHA.106.179568","volume":"114","author":"Kavey","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000444143","article-title":"Growth hormone deficiency in prepubertal children: predictive markers of cardiovascular disease","volume":"85","author":"De Leonibus","year":"2016","journal-title":"Horm Res Paediatr"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ghir.2015.08.005","article-title":"Growth hormone and the risk of atherosclerosis in growth hormone-deficient children","volume":"25","author":"Binay","year":"2015","journal-title":"Growth Horm IGF Res"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib39","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2008-2639","article-title":"Subtle alterations of cardiac performance in children with growth hormone deficiency: results of a two-year prospective, case-control study","volume":"94","author":"Capalbo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib40","first-page":"209","article-title":"Metabolic abnormalities in growth hormone deficiency","volume":"2","author":"Lanes","year":"2004","journal-title":"Pedia Endocrinol Rev"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.4103\/2230-8210.117234","article-title":"Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: a single-center prospective case-control study","volume":"17","author":"Metwalley","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.2002.01568.x","article-title":"Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan","volume":"57","author":"Gleeson","year":"2002","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.beem.2023.101821_bib43","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1210\/jc.2005-0091","article-title":"Endothelial function, carotid artery intima-media thickness, epicardial adipose tissue, and left ventricular mass and function in growth hormone-deficient adolescents: apparent effects of growth hormone treatment on these parameters","volume":"90","author":"Lanes","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1210\/jc.2005-0981","article-title":"Improvement of cardiac performance and cardiovascular risk factors in children with GH deficiency after two years of GH replacement therapy: an observational, open, prospective, case-control study","volume":"91","author":"Salerno","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2023.101821_bib45","first-page":"2653","article-title":"Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy","volume":"82","author":"al-Shoumer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib46","first-page":"291","article-title":"Cardiovascular risk of young growth-hormone-deficient adolescents. Differences in growth-hormone-treated and untreated patients","volume":"60","author":"Lanes","year":"2003","journal-title":"Horm Res"},{"issue":"11","key":"10.1016\/j.beem.2023.101821_bib47","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4158\/GL-2019-0405","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care","volume":"25","author":"Yuen","year":"2019","journal-title":"Endocr Pr"},{"issue":"10","key":"10.1016\/j.beem.2023.101821_bib48","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3345\/kjp.2010.53.10.892","article-title":"Prevalence and risk factors of the metabolic syndrome in young adults with childhood-onset hypopituitary growth hormone deficiency","volume":"53","author":"Lim","year":"2010","journal-title":"Korean J Pedia"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib49","doi-asserted-by":"crossref","first-page":"32","DOI":"10.6065\/apem.2014.19.1.32","article-title":"Efficacy of growth hormone therapy in adults with childhood-onset growth hormone deficiency","volume":"19","author":"Kim","year":"2014","journal-title":"Ann Pedia Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3803\/EnM.2021.1384","article-title":"Metabolic impacts of discontinuation and resumption of recombinant human growth hormone treatment during the transition period in patients with childhood-onset growth hormone deficiency","volume":"37","author":"Lee","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"10.1016\/j.beem.2023.101821_bib51","first-page":"749","article-title":"Impact of discontinuation of growth hormone treatment on lipids and weight status in adolescents","volume":"30","author":"Rothermel","year":"2017","journal-title":"J Pedia Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib52","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1210\/jc.2009-2013","article-title":"Discontinuation of growth hormone (GH) treatment during the transition phase is an important factor determining the phenotype of young adults with nonidiopathic childhood-onset GH deficiency","volume":"95","author":"Ko\u0142towska-H\u00e4ggstr\u00f6m","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib53","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jcem.87.3.8336","article-title":"The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study","volume":"87","author":"Colao","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib54","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-13-0572","article-title":"Monocentric study of 112 consecutive patients with childhood onset GH deficiency around and after transition","volume":"169","author":"Courtillot","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2023.101821_bib55","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2023.101821_bib56","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/jc.2003-031588","article-title":"Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth","volume":"89","author":"Carroll","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2023.101821_bib57","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1210\/jc.2005-0208","article-title":"Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial","volume":"90","author":"Mauras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4274\/jcrpe.0010","article-title":"Prospective follow-up of children with idiopathic growth hormone deficiency after termination of growth hormone treatment: is there really need for treatment at transition to adulthood?","volume":"10","author":"\u00c7amtosun","year":"2018","journal-title":"J Clin Res Pedia Endocrinol"},{"issue":"18","key":"10.1016\/j.beem.2023.101821_bib59","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1016\/j.molcel.2021.08.027","article-title":"Lipid metabolism in sickness and in health: emerging regulators of lipotoxicity","volume":"81","author":"Yoon","year":"2021","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2680001","article-title":"Assembly and secretion of hepatic very-low-density lipoprotein","volume":"268","author":"Gibbons","year":"1990","journal-title":"Biochem J"},{"issue":"8","key":"10.1016\/j.beem.2023.101821_bib61","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/BF00400586","article-title":"Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM","volume":"38","author":"Cummings","year":"1995","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0021-9150(94)05430-Q","article-title":"Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study","volume":"113","author":"Cummings","year":"1995","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib63","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.ATV.13.5.629","article-title":"Substrate delivery as a determinant of hepatic apoB secretion","volume":"13","author":"Sniderman","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib64","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-2275(20)40744-8","article-title":"Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells","volume":"34","author":"Dixon","year":"1993","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib65","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1210\/en.2003-0518","article-title":"Sex difference in hepatic microsomal triglyceride transfer protein expression is determined by the growth hormone secretory pattern in the rat","volume":"144","author":"Am\u00e9en","year":"2003","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.beem.2023.101821_bib66","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1161\/01.ATV.17.12.3542","article-title":"Lipoprotein heterogeneity and apolipoprotein B metabolism","volume":"17","author":"Packard","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib67","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","article-title":"Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee","volume":"83","author":"Carroll","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl A","key":"10.1016\/j.beem.2023.101821_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1096-6374(99)80002-1","article-title":"Effects of growth hormone on hepatic cholesterol metabolism. Lessons from studies in rats and humans","volume":"9","author":"Rudling","year":"1999","journal-title":"Growth Horm IGF Res"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib69","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1210\/endo.136.9.7649083","article-title":"Growth hormone specifically stimulates the expression of low density lipoprotein receptors in human hepatoma cells","volume":"136","author":"Parini","year":"1995","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib70","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/01.ATV.19.4.832","article-title":"Cholesterol and lipoprotein metabolism in aging: reversal of hypercholesterolemia by growth hormone treatment in old rats","volume":"19","author":"Parini","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/j.beem.2023.101821_bib71","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1073\/pnas.89.15.6983","article-title":"Importance of growth hormone for the induction of hepatic low density lipoprotein receptors","volume":"89","author":"Rudling","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib72","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00041433-199405030-00002","article-title":"Growth hormone and hepatic lipoprotein metabolism","volume":"5","author":"Angelin","year":"1994","journal-title":"Curr Opin Lipido"},{"issue":"6257","key":"10.1016\/j.beem.2023.101821_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib74","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0022-2275(20)42002-4","article-title":"Quantitation of plasma mevalonic acid using gas chromatography-electron capture mass spectrometry","volume":"32","author":"Scoppola","year":"1991","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib75","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/jcem-57-5-885","article-title":"The role of human growth hormone in the regulation of cholesterol and bile acid metabolism","volume":"57","author":"Heubi","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib76","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1172\/JCI119398","article-title":"Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7alpha-hydroxylase in the rat","volume":"99","author":"Rudling","year":"1997","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib77","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","article-title":"Human growth hormone and human aging","volume":"14","author":"Corpas","year":"1993","journal-title":"Endocr Rev"},{"issue":"5","key":"10.1016\/j.beem.2023.101821_bib78","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJM198508013130501","article-title":"Influence of age on secretion of cholesterol and synthesis of bile acids by the liver","volume":"313","author":"Einarsson","year":"1985","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.0.1400203","article-title":"Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized rats","volume":"140","author":"Vikman-Adolfsson","year":"1994","journal-title":"J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0026-0495(84)90124-0","article-title":"Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities","volume":"33","author":"Asayama","year":"1984","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0026-0495(96)90293-0","article-title":"Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity","volume":"45","author":"Oscarsson","year":"1996","journal-title":"Metabolism"},{"issue":"2 Pt 1","key":"10.1016\/j.beem.2023.101821_bib82","first-page":"E211","article-title":"Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity","volume":"266","author":"Richelsen","year":"1994","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib83","first-page":"2010","article-title":"Abnormalities of very low density lipoprotein apolipoprotein B-100 metabolism contribute to the dyslipidaemia of adult growth hormone deficiency","volume":"82","author":"Cummings","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib84","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2337\/diab.32.6.525","article-title":"The response of plasma triglyceride, cholesterol, and lipoprotein lipase to treatment in non-insulin-dependent diabetic subjects without familial hypertriglyceridemia","volume":"32","author":"Pfeifer","year":"1983","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib85","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/diab.31.3.217","article-title":"Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus","volume":"31","author":"Kissebah","year":"1982","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib86","first-page":"307","article-title":"Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study","volume":"84","author":"Christ","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib87","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/eje.1.02105","article-title":"Low-density lipoprotein apolipoprotein B100 turnover in hypopituitary patients with GH deficiency: a stable isotope study","volume":"154","author":"Christ","year":"2006","journal-title":"Eur J Endocrinol"},{"issue":"5 Suppl","key":"10.1016\/j.beem.2023.101821_bib88","first-page":"2","article-title":"Effects of growth hormone on lipoprotein lipase and hepatic lipase","volume":"22","author":"Oscarsson","year":"1999","journal-title":"J Endocrinol Invest"},{"issue":"5 Suppl","key":"10.1016\/j.beem.2023.101821_bib89","first-page":"10","article-title":"Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans","volume":"22","author":"Richelsen","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.beem.2023.101821_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154188","article-title":"Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individuals","volume":"105","author":"Hjelholt","year":"2020","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib91","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1210\/jc.2003-031474","article-title":"Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study","volume":"89","author":"Christ","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib92","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1172\/JCI115796","article-title":"Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion","volume":"89","author":"Zenobi","year":"1992","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib93","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1172\/JCI116109","article-title":"Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus","volume":"90","author":"Zenobi","year":"1992","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib94","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1172\/JCI118415","article-title":"Regulation of rat hepatic low density lipoprotein receptors. In vivo stimulation by growth hormone is not mediated by insulin-like growth factor I","volume":"97","author":"Rudling","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib95","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2005.08.013","article-title":"Low-density lipoprotein size and cardiovascular prevention","volume":"17","author":"Rizzo","year":"2006","journal-title":"Eur J Intern Med"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0022-2275(20)32065-4","article-title":"Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions","volume":"41","author":"Packard","year":"2000","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.beem.2023.101821_bib97","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1194\/jlr.R200004-JLR200","article-title":"Metabolic origins and clinical significance of LDL heterogeneity","volume":"43","author":"Berneis","year":"2002","journal-title":"J Lipid Res"},{"issue":"25","key":"10.1016\/j.beem.2023.101821_bib98","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib99","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-06-0652","article-title":"Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy","volume":"156","author":"Rizzo","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ghir.2007.10.003","article-title":"Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency","volume":"18","author":"Rizzo","year":"2008","journal-title":"Growth Horm IGF Res"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib101","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0950-351X(95)80145-6","article-title":"Lipoprotein (a)","volume":"9","author":"Durrington","year":"1995","journal-title":"Baillieres Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2023.101821_bib102","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0021-9150(86)90099-7","article-title":"The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels","volume":"62","author":"Armstrong","year":"1986","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.beem.2023.101821_bib103","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.1996.03540070040028","article-title":"Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study","volume":"276","author":"Bostom","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib104","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.0.1340061","article-title":"An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adult acquired growth hormone deficiency","volume":"134","author":"Garry","year":"1996","journal-title":"Eur J Endocrinol"},{"issue":"Pt 4","key":"10.1016\/j.beem.2023.101821_bib106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1177\/000456329603300408","article-title":"Increased serum lipoprotein(a) concentrations after growth hormone (GH) treatment in patients with isolated GH deficiency","volume":"33","author":"O'Halloran","year":"1996","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib107","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/eje.0.1360377","article-title":"Growth hormone increases and insulin-like growth factor-I decreases circulating lipoprotein(a)","volume":"136","author":"Laron","year":"1997","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2023.101821_bib108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0021-9150(97)00110-X","article-title":"The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone-deficient adults","volume":"133","author":"Webster","year":"1997","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib109","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.1995.tb02699.x","article-title":"Recombinant human insulin-like growth factor-I decreases serum lipoprotein(a) concentrations in normal adult men","volume":"42","author":"Oscarsson","year":"1995","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.beem.2023.101821_bib110","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.beem.2023.101821_bib111","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s00125-010-1738-4","article-title":"Improved insulin sensitivity, preserved beta cell function and improved whole-body glucose metabolism after low-dose growth hormone replacement therapy in adults with severe growth hormone deficiency: a pilot study","volume":"53","author":"Arafat","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.beem.2023.101821_bib112","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02359.x","article-title":"Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency","volume":"63","author":"Yuen","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"10.1016\/j.beem.2023.101821_bib113","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study","volume":"98","author":"B\u00f6ger","year":"1996","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib114","first-page":"453","article-title":"Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults","volume":"84","author":"Pfeifer","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2023.101821_bib115","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1530\/EJE-11-1028","article-title":"Overall and cause-specific mortality in GH-deficient adults on GH replacement","volume":"166","author":"Gaillard","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2023.101821_bib116","first-page":"203","article-title":"Decrease of small dense LDL and lipoprotein-associated phospholipase A2 due to human growth hormone treatment in short children with growth hormone deficiency and small for gestational age status","volume":"29","author":"Krebs","year":"2016","journal-title":"J Pedia Endocrinol Metab"},{"issue":"6441","key":"10.1016\/j.beem.2023.101821_bib117","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/365065a0","article-title":"Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia","volume":"365","author":"Sharp","year":"1993","journal-title":"Nature"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X23000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:01:11Z","timestamp":1761498071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X23000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":117,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1521690X23000957"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2023.101821","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidaemia and growth hormone deficiency \u2013 A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2023.101821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101821"}}